Genetic Analysis AS (GA) is a science-based diagnostic company and pioneer in the human microbiome field with more than 10 years of expertise in research and product development. The unique GA-map® platform is based on a pre-targeted multiplex approach specialized for simultaneous analysis of a large number of bacteria in one reaction
The overall turnaround time for the GA-map® assay in the lab is 1-2 days.
The test has been validated using independent cohorts of clinically validated healthy volunteers, IBS and IBD patients.
Innovative probe-based technology that represents the next step in gut microbiota routine analysis and diagnostic.
Senior Professor at the Ludwig Maximillian University, University Clinic in Munich, Germany
Emeritus Professor Peter Malfertheiner
"There is still so much to learn about the microbiome, we are only just beginning to discover its importance, and the GA-map Test will help us do just that."
Stord Hospital, Helse Bergen and the University of Bergen, Norway
Professor Magdy El-Salhy
"We used GA-map® in our clinical research within IBS. We have great experience with GA-map® as a tool to select, monitor and follow-up patients."
GA-map® Dysbiosis Test is CE-IVD marked, standardized for clinical routine testing and provides easy to interpret results.
Fill in the form, and we will send some FREE resources about the future of microbiome testing.
YoJoin us in person at La Nuvola - Roma Convention Group at booth #97a.
Genetic Analysis AS (GA) is a Norwegian science-based diagnostic company and pioneer in the human microbiome field with more than 10 years of expertise in research and product development.
Feel free to connect with us on LinkedIn.
Genetic Analysis is attending Worldlab Euromedlab in Rome 21-25 May 2023. Join us at booth #97a and meet our team of microbiome experts and enthusiasts. We are looking forward to discussing the future of diagnostics and how we can help you in setting up a gut microbiome analysis platform, the GA-map®.